Characterising the policy influence of peer-based drug user organisations in the context of hepatitis C elimination

Graham Brown, Gari-Emma Perry, Jude Byrne, Sione Crawford, Charles Henderson, Annie Madden, Roanna Lobo, Daniel Reeders

    Research output: Contribution to journalArticle

    Abstract

    Background: Achieving hepatitis C (HCV) elimination goals will require major policy and health service reorientation to scale up testing and treatment among people who inject drugs (PWID). To achieve this, a close partnership with peer-based drug user organisations is required. However, peer organisations have historical and ongoing difficulties in articulating the validity of their service delivery and policy advice, leading to some policy and health services resisting partnership and advice from peer-based drug user organisations.
    Original languageEnglish
    Pages (from-to)24-32
    JournalInternational Journal of Drug Policy
    Volume72
    DOIs
    Publication statusPublished - 2019

    Fingerprint Dive into the research topics of 'Characterising the policy influence of peer-based drug user organisations in the context of hepatitis C elimination'. Together they form a unique fingerprint.

    Cite this